Concepedia

Briana Ndife

BN

Statistics

Publications

8

Citations

158

H-Index

8

Active since

2018

Affiliations

Novartis (United States)(Current)

Tris Pharma (United States)

Group for Research in Decision Analysis

Analysis Group (United States)

Cleveland Clinic

Briana Ndife is an author at Novartis (United States) specializing in oncology, medicine, and cost-effectiveness analysis.

Publications per year

2018–2022

8

Publications

8

Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study

Jason J. Luke, Sameer R. Ghate, Jonathan Kish et al. · Future Oncology · 2019 · 38 citations · Full text

Medicine, Immunology, Oncology +13

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma

Ahmad A. Tarhini, Sameer R. Ghate, Raluca Ionescu‐Ittu et al. · Melanoma Research · 2018 · 31 citations · Full text

Medicine, Oncology, Surgery +17

Patient Preferences for Treatment of Metastatic Melanoma

Carol Mansfield, Briana Ndife, Joyce Chen et al. · Future Oncology · 2019 · 21 citations · Full text

Medicine, Oncology, Immunotherapy +13

Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States

Karen Seiter, Dominick Latrémouille-Viau, Annie Guérin et al. · Advances in Therapy · 2018 · 17 citations

Medicine, Oncology, Pharmacotherapy +13

Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States

Eytan M. Stein, Jipan Xie, Emilie D. Duchesneau et al. · PharmacoEconomics · 2018 · 14 citations

Pharmacy, Oncology, Pharmacoeconomics +13

1–5 of 8